Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Dendritic cells loaded with apoptotic tumour cells induce a stronger T-cell response than dendritic cell–tumour hybrids in B-CLL

Leukemia volume 17, pages 894–899 (2003)Cite this article

Abstract

Dendritic cells (DC) are professional (specialised) antigen-presenting cells that can capture antigen from apoptotic tumour cells and induce MHC class I- and II-restricted responses. Also, DC fused with tumour cells may be effective for immune response induction. Both cell preparations may be considered as vaccine candidates in a therapeutic approach. We examined autologous T-cell activation by DC that had endocytosed leukaemic B-cell apoptotic bodies (Apo-DC) and compared it to the T-cell stimulatory capacity of DC that were fused with tumour cells. Following incubation, 22.6±6.2 (mean±s.e.m.) of DC had endocytosed leukaemic cells, while the frequency of DC–leukaemic cell hybrids was 10.5±2.6%. Apo-DC and hybrid cells both demonstrated the ability to stimulate a tumour-specific T-cell immune response in vitro. A T-cell proliferation response was also observed in four out of five CLL patients when using Apo-DC. However, fusion hybrids lacked the ability to elicit a proliferative response. Apo-DC also induced an IFN-γ response, as did hybrid cells. The cytokine response induced by Apo-DC was significantly higher than that induced by fusion (P<0.05). This study shows that endocytosed apoptotic tumour cells induced a significantly stronger T-cell response than DC hybrids; and as such should be a better candidate for vaccine production.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Berger CL, Xu AL, Hanlon D, Lee C, Schechner J, Glusac E . Induction of human tumor-loaded dendritic cells. Int J Cancer 2001; 91: 438–447.

    Article  CAS  PubMed  Google Scholar 

  2. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ . Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767–811.

    Article  CAS  PubMed  Google Scholar 

  3. Biragyn A, Kwak LW . Designer cancer vaccines are still in fashion. Nat Med 2000; 6: 966–968.

    Article  CAS  PubMed  Google Scholar 

  4. Rezvany MR, Jeddi-Tehrani M, Rabbani H, Lewin N, Avila-Carino J, Osterborg A . Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia. Br J Haematol 2000a; 111: 608–617.

    Article  CAS  PubMed  Google Scholar 

  5. Gong J, Chen D, Kashiwaba M, Kufe D . Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat Med 1997; 3: 558–561.

    Article  CAS  PubMed  Google Scholar 

  6. Rovere P, Vallinoto C, Bondanza A, Crosti MC, Rescigno M, Ricciardi-Castagnoli P . Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol 1998; 161: 4467–4471.

    CAS  PubMed  Google Scholar 

  7. Albert ML, Sauter B, Bhardwaj N . Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392: 86–89.

    Article  CAS  PubMed  Google Scholar 

  8. Henry F, Bretaudeau L, Barbieux I, Meflah K, Gregoire M . Induction of antigen presentation by macrophages after phagocytosis of tumour apoptotic cells. Res Immunol 1998; 149: 673–679.

    Article  CAS  PubMed  Google Scholar 

  9. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS . Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234.

    CAS  PubMed  Google Scholar 

  10. Idestrom K, Kimby E, Bjorkholm M, Mellstedt H, Engstedt L, Gahrton G . Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone. Eur J Cancer Clin Oncol 1982; 18: 1117–1123.

    Article  CAS  PubMed  Google Scholar 

  11. Avila-Carino J, Lewin N, Yamamoto K, Tomita Y, Mellstedt H, Brodin B . EBV infection of B-CLL cells in vitro potentiates their allostimulatory capacity if accompanied by acquisition of the activated phenotype. Int J Cancer 1994; 58: 678–685.

    Article  CAS  PubMed  Google Scholar 

  12. Boyum A . Separation of lymphocytes, lymphocyte subgroups and monocytes: a review. Lymphology 1977; 10: 71–76.

    CAS  PubMed  Google Scholar 

  13. Rezvany MR, Jeddi-Tehrani M, Biberfeld P, Soderlund J, Mellstedt H, Osterborg A . Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern. Br J Haematol 2001; 115: 263–271.

    Article  CAS  PubMed  Google Scholar 

  14. Mendes R, Bromelow KV, Westby M, Galea-Lauri J, Smith IE, O'Brien ME . Flow cytometric visualisation of cytokine production by CD3− CD56+ NK cells and CD3+ CD56+ NK-T cells in whole blood. Cytometry 2000; 39: 72–78.

    Article  CAS  PubMed  Google Scholar 

  15. Rezvany MR, Jeddi-Tehrani M, Rabbani H, Ruden U, Hammarstrom L, Osterborg A . Autologous T lymphocytes recognize the tumour-derived immunoglobulin VH-CDR3 region in patients with B-cell chronic lymphocytic leukaemia. Br J Haematol 2000b; 111: 230–238.

    Article  CAS  PubMed  Google Scholar 

  16. Gong J, Nikrui N, Chen D, Koido S, Wu Z, Tanaka Y . Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity. J Immunol 2000; 165: 1705–1711.

    Article  CAS  PubMed  Google Scholar 

  17. Comby E, Andre I, Troussard X, Lebrun E, Sola B, Ballet JJ . In vitro evaluation of B-CLL cells apoptotic responses to irradiation. Leukaemia Lymphoma 1999; 34: 159–166.

    Article  CAS  Google Scholar 

  18. Osterborg A, Yi Q, Henriksson L, Fagerberg J, Bergenbrant S, Jeddi-Tehrani M . Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses. Blood 1998; 91: 2459–2466.

    CAS  PubMed  Google Scholar 

  19. Buhmann R, Nolte A, Westhaus D, Emmerich B, Hallek M . CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T-cells generates different types of effector cells. Blood 1999; 93: 1992–2002.

    CAS  PubMed  Google Scholar 

  20. Kato K, Cantwell MJ, Sharma S, Kipps TJ . Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells. J Clin Invest 1998; 101: 1133–1141.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Fagerberg J, Yi Q, Gigliotti D, Harmenberg U, Ruden U, Persson B . T-cell-epitope mapping of the idiotypic monoclonal IgG heavy and light chains in multiple myeloma. Int J Cancer 1999; 80: 671–680.

    Article  CAS  PubMed  Google Scholar 

  22. Wen YJ, Lim SH . T-cells recognize the VH complementarity-determining region 3 of the idiotypic protein of B cell non-Hodgkin's lymphoma. Eur J Immunol 1997; 27: 1043–1047.

    Article  CAS  PubMed  Google Scholar 

  23. Wen YJ, Lim SH . In vivo immune responses to idiotypic VH complementarity-determining region 3 peptide vaccination in B-cell non-Hodgkin's lymphoma. Br J Haematol 1998; 103: 663–668.

    Article  CAS  PubMed  Google Scholar 

  24. Hoffmann TK, Meidenbauer N, Dworacki G, Kanaya H, Whiteside TL . Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells. Cancer Res 2000; 60: 3542–3549.

    CAS  PubMed  Google Scholar 

  25. Henry F, Boisteau O, Bretaudeau L, Lieubeau B, Meflah K, Gregoire M . Antigen-presenting cells that phagocytose apoptotic tumor-derived cells are potent tumor vaccines. Cancer Res 1999; 59: 3329–3332.

    CAS  PubMed  Google Scholar 

  26. Inaba K, Turley S, Yamaide F, Iyoda T, Mahnke K, Inaba M . Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 1998; 188: 2163–2173.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Chen Z, Moyana T, Saxena A, Warrington R, Jia Z, Xiang J . Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells. Int J Cancer 2001; 93: 539–548.

    Article  CAS  PubMed  Google Scholar 

  28. Gong J, Avigan D, Chen D, Wu Z, Koido S, Kashiwaba M . Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells. Proc Natl Acad Sci USA 2000; 97: 2715–2718.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Schnurr M, Scholz C, Rothenfusser S, Galambos P, Dauer M, Robe J . Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T-cells and activate NK and gammadelta T-cells. Cancer Res 2002; 62: 2347–2352.

    CAS  PubMed  Google Scholar 

  30. Li JLMH, Franek KJ, Burgin KE, Wagner TE, Wei Y . Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunity. Cancer Immunol Immunother 2001; 50: 445–455.

    Article  Google Scholar 

  31. Speidel K, Osen W, Faath S, Hilgert I, Obst R, Braspenning J . Priming of cytotoxic T lymphocytes by five heat-aggregated antigens in vivo: conditions, efficiency, and relation to antibody responses. Eur J Immunol 1997; 27: 2391–2399.

    Article  CAS  PubMed  Google Scholar 

  32. Kneitz C, Goller M, Wilhelm M, Mehringer C, Wohlleben G, Schimpl A . Inhibition of T-cell/B-cell interaction by B-CLL cells. Leukemia 1999; 13: 98–104.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from The Swedish Cancer Foundation, The Cancer Society in Stockholm, King Gustav Vth Jubilee Fund, The Karolinska Institutet Foundation, the Swedish Medical Society, and the Swedish Society for Medical Research, Gunnar Nilsson Foundation, and the Cancer and Allergy Foundation, and the Torsten and Ragnar Söderberg Foundation.

The authors gratefully acknowledge Lillemor Lauren for technical assistance.

Author information

Authors and Affiliations

  1. Immune and Gene Therapy Laboratory, CCK, Karolinska Hospital, Stockholm, Sweden

    P Kokhaei, M R Rezvany, L Virving, A Choudhury, H Rabbani & H Mellstedt

  2. Department of Oncology (Radiumhemmet), Karolinska Hospital, Stockholm, Sweden

    A Österborg & H Mellstedt

  3. Department of Hematology, Karolinska Hospital, Stockholm, Sweden

    A Österborg & H Mellstedt

Authors
  1. P Kokhaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M R Rezvany
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L Virving
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Choudhury
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H Rabbani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Österborg
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H Mellstedt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kokhaei, P., Rezvany, M., Virving, L. et al. Dendritic cells loaded with apoptotic tumour cells induce a stronger T-cell response than dendritic cell–tumour hybrids in B-CLL. Leukemia 17, 894–899 (2003). https://doi.org/10.1038/sj.leu.2402913

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402913

Keywords

This article is cited by

Search

Advanced search

Quick links